Silvant Capital Management LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 23,347 shares of the company's stock, valued at approximately $11,277,000.
Several other institutional investors and hedge funds have also made changes to their positions in ALAB. Glenmede Trust Co. NA boosted its stake in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company's stock valued at $209,000 after buying an additional 51 shares in the last quarter. Lido Advisors LLC boosted its position in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock worth $2,046,000 after acquiring an additional 57 shares during the period. Goldstein Advisors LLC grew its holdings in shares of Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company's stock valued at $268,000 after acquiring an additional 88 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $43,000. Finally, Bell Investment Advisors Inc bought a new stake in Astera Labs in the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors.
Astera Labs News Summary
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Scorpio growth is becoming the key catalyst: Analysts expect Scorpio to overtake Aries as Astera Labs’ largest product family, increasing the company’s semiconductor content per AI accelerator. Third-quarter revenue guidance implies approximately 40% sequential growth to about $550 million, while operating margins are expected to approach 43%. Astera Labs: Scorpio Is Becoming The Real Story
- Positive Sentiment: AI connectivity demand remains strong: Recent coverage points to record demand for Astera’s data-center connectivity products as hyperscalers and other customers expand AI infrastructure. The company’s latest quarter showed revenue growth of 104.5% year over year to $392.4 million, while EPS exceeded consensus estimates. Astera Labs stock in focus on record AI-connectivity demand
- Positive Sentiment: Analyst sentiment improved: Northland Securities upgraded ALAB to “Outperform.” MarketBeat reports a “Moderate Buy” consensus rating and an average price target of $333, while other analysts have raised targets following the company’s earnings report. Northland Securities Upgrades Astera Labs to Outperform
- Positive Sentiment: Strong relative growth profile: Comparisons with Credo and monday.com emphasize Astera’s accelerating quarterly revenue trajectory and exposure to AI connectivity, though investors should remember these are opinion-based comparisons rather than new company guidance. Credo vs. Astera Labs: Which AI Connectivity Stock Is the Better Buy?
- Neutral Sentiment: Insider sales were tax-related: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares totaling roughly $64 million. The filings state the transactions covered tax withholding from vested equity awards, and each executive retained a substantial position; nevertheless, the sales could weigh on short-term sentiment. SEC insider transaction filing
- Negative Sentiment: Valuation and technical pressure remain risks: Astera trades at a price-to-earnings ratio above 140 and below its 50-day moving average. With a beta near 3.8, the stock is particularly sensitive to profit-taking and shifts in AI-sector sentiment after its sharp prior rally.
Insider Buying and Selling
In related news, CEO Jitendra Mohan sold 90,630 shares of the company's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This represents a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock valued at $163,135,169 in the last 90 days. 10.40% of the stock is currently owned by corporate insiders.
Astera Labs Trading Up 0.5%
NASDAQ ALAB opened at $290.52 on Friday. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The company has a market cap of $50.40 billion, a PE ratio of 143.82 and a beta of 3.84. The stock has a 50 day moving average of $354.34 and a 200-day moving average of $244.64.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the business earned $0.44 earnings per share. The business's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Analysts Set New Price Targets
Several brokerages have recently issued reports on ALAB. Bank of America raised their price target on Astera Labs from $240.00 to $450.00 and gave the company a "neutral" rating in a research report on Tuesday, June 23rd. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a "neutral" rating and a $153.00 target price on the stock. Weiss Ratings reissued a "hold (c)" rating on shares of Astera Labs in a report on Tuesday. Morgan Stanley lifted their price target on shares of Astera Labs to $335.00 and gave the stock an "overweight" rating in a research report on Monday, August 3rd. Finally, Needham & Company LLC upped their target price on shares of Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $333.00.
View Our Latest Analysis on ALAB
About Astera Labs
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.